Interventions for American cutaneous and mucocutaneous leishmaniasis
Mariona Pinart, José-Ramón Rueda, Gustavo Adolfo Sierra Romero, Carlos Eduardo Pinzón-Flórez, Karime Osorio-Arango, Ana Nilce Silveira Maia‐Elkhoury, Ludovic Revéiz, Vanessa Elías, J.A. Tweed
Abstract
On the American continent, cutaneous and mucocutaneous leishmaniasis (CL and MCL) are diseases associated with infection by several species of Leishmania parasites. Pentavalent antimonials remain the first-choice treatment. There are alternative interventions, but reviewing their effectiveness and safety is important as availability is limited. This is an update of a Cochrane Review first published in 2009.
Topics & Concepts
MedicineMucocutaneous zonePsychological interventionAdverse effectLeishmaniasisMEDLINEPlaceboCutaneous leishmaniasisClinical trialRandomized controlled trialRelative riskDermatologySurgeryInternal medicinePediatricsPathologyAlternative medicineDiseaseConfidence intervalLawPolitical sciencePsychiatryResearch on Leishmaniasis Studies